Literature DB >> 9632786

Adenovirus E1B 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription.

R H See1, Y Shi.   

Abstract

Adenovirus E1B proteins (19,000-molecular-weight [19K] and 55K proteins) inhibit apoptosis and cooperate with adenovirus E1A to induce full oncogenic transformation of primary cells. The E1B 19K protein has previously been shown to be capable of activating transcription; however, the underlying mechanisms are unclear. Here, we show that adenovirus infection activates the c-Jun N-terminal kinase (JNK) and that the E1B gene products are necessary for adenovirus to activate JNK. In transfection assays, we show that the E1B 19K protein is sufficient to activate JNK and can strongly induce c-Jun-dependent transcription. Mapping studies show that the C-terminal portion of E1B 19K is necessary for induction of c-Jun-mediated transcription. Using dominant-negative mutants of several kinases upstream of JNK, we show that MEKK1 and MKK4, but not Ras, are involved in the induction of JNK activity by adenovirus infection. The same dominant-negative kinase mutants also block the ability of E1B 19K to induce c-Jun-mediated transcription. Taken together, these results suggest that E1B 19K may utilize the MEKK1-MKK4-JNK signaling pathway to activate c-Jun-dependent transcription and demonstrate a novel, kinase-activating activity of E1B 19K that may underlie its ability to regulate transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632786      PMCID: PMC108986          DOI: 10.1128/MCB.18.7.4012

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

1.  Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein.

Authors:  Y Shi; E Seto; L S Chang; T Shenk
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

Review 2.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

Authors:  P Angel; M Karin
Journal:  Biochim Biophys Acta       Date:  1991-12-10

3.  Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes.

Authors:  K Yoshida; L Venkatesh; M Kuppuswamy; G Chinnadurai
Journal:  Genes Dev       Date:  1987-09       Impact factor: 11.361

4.  Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff.

Authors:  D N Halbert; J R Cutt; T Shenk
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

5.  The adenovirus E1B 19-kilodalton protein stimulates gene expression by increasing DNA levels.

Authors:  C H Herrmann; M B Mathews
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

6.  Tandemly repeated hexamer sequences within the beta interferon promoter can function as an inducible regulatory element in activation by the adenovirus E1B 19-kilodalton protein.

Authors:  K Shiroki; H Kato; S Kawai
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein.

Authors:  E White; R Cipriani
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

8.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.

Authors:  P R Yew; A J Berk
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

9.  Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein.

Authors:  S A Rice; D F Klessig
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

10.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

Authors:  C Yee; I Krishnan-Hewlett; C C Baker; R Schlegel; P M Howley
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

View more
  12 in total

1.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells.

Authors:  Beata Sadowska; Robert Barrucco; Kamel Khalili; Mahmut Safak
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy.

Authors:  Stephen L Wechman; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Heshan Sam Zhou; Kelly M McMasters
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

4.  Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun.

Authors:  P Clarke; S M Meintzer; C Widmann; G L Johnson; K L Tyler
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.

Authors:  G M Kasof; L Goyal; E White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB.

Authors:  C C Weihl; G D Ghadge; S G Kennedy; N Hay; R J Miller; R P Roos
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

7.  Enhancement of recombinant adeno-associated virus type 2-mediated transgene expression in a lung epithelial cell line by inhibition of the epidermal growth factor receptor.

Authors:  Andrew D Smith; Roy F Collaco; James P Trempe
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  ERK- and JNK-dependent signaling pathways contribute to Bombyx mori nucleopolyhedrovirus infection.

Authors:  Susumu Katsuma; Kazuei Mita; Toru Shimada
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  Microarray and pathway analysis reveals decreased CDC25A and increased CDC42 associated with slow growth of BCL2 overexpressing immortalized breast cell line.

Authors:  Jacquelyn M Long; Charles W Bell; W Samuel Fagg; Mary E Kushman; Kevin G Becker; James A McCubrey; Mary A Farwell
Journal:  Cell Cycle       Date:  2008-10-08       Impact factor: 4.534

10.  Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.

Authors:  Jorge G Gomez-Gutierrez; Jonathan Nitz; Rajesh Sharma; Stephen L Wechman; Eric Riedinger; Elvis Martinez-Jaramillo; Heshan Sam Zhou; Kelly M McMasters
Journal:  Virology       Date:  2015-11-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.